Fiche société
Taiho Pharmaceutical Co., Ltd.
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| TAS-205 [Ambulatory Cohort] [Non-ambulatory Cohort]The purpose of this study is to evaluate the efficacy and safety of TAS-205 in patients with Duchenne muscular dystrophy | Myopathies | Phase 3 | À vérifier | Japan | À vérifier |
| TAS-205 [Ambulatory Cohort] [Non-ambulatory Cohort]The purpose of this study is to evaluate the efficacy and safety of TAS-205 in patients with Duchenne muscular dystrophy | Myopathies | Phase 3 | À vérifier | Japan | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| TAS-205 [Ambulatory Cohort] [Non-ambulatory Cohort] | Myopathies | Phase 3 | NCT04587908 | A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD） | COMPLETED |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||